Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Exchange Rate Effect (2022 - 2026)

Cardiol Therapeutics filings provide 1 years of Exchange Rate Effect readings, the most recent being $4.8 million for Q4 2022.

  • On a quarterly basis, Exchange Rate Effect changed N/A to $4.8 million in Q4 2022 year-over-year; TTM through Dec 2022 was $2.0 million, a N/A change, with the full-year FY2025 number at -$589783.8, down 142.72% from a year prior.
  • Exchange Rate Effect hit $4.8 million in Q4 2022 for Cardiol Therapeutics, up from -$2.5 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $4.8 million in Q4 2022 to a low of -$2.5 million in Q3 2022.